West Pharmaceutical Services WST Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed October 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's interest coverage?
- West Pharmaceutical Services (WST) reported interest coverage of 114.2× in Q3 2024.
- How has West Pharmaceutical Services's interest coverage changed year-over-year?
- West Pharmaceutical Services's interest coverage increased by 68.3% year-over-year, from 67.9× to 114.2×.
- What is the long-term trend for West Pharmaceutical Services's interest coverage?
- Over 2 years (2021 to 2023), West Pharmaceutical Services's interest coverage has grown at a -1.8% compound annual growth rate (CAGR), from 317× to 305.8×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.